These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8506414)

  • 21. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early diagnosis of cutaneous melanoma and its precursors. Importance of the clinical characteristics of thin melanoma].
    Cristofolini M; Zumiani G; Boi S; Piscioli F; Qiqi C
    Minerva Med; 1986 Sep; 77(37):1673-8. PubMed ID: 3763038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and histopathologic analyses of pigmented macular lesions on the soles of Japanese--proposal of a clinical guideline for detection of early malignant melanoma on the sole].
    Saida T; Yoshida N
    Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):117-28. PubMed ID: 2746966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
    J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic vessel density is significantly increased in melanoma.
    Giorgadze TA; Zhang PJ; Pasha T; Coogan PS; Acs G; Elder DE; Xu X
    J Cutan Pathol; 2004 Nov; 31(10):672-7. PubMed ID: 15491327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
    Ribé A
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dysplastic melanocytic nevi. 2 steps backward and 1 forward].
    Urso C
    Pathologica; 1997 Aug; 89(4):377-83. PubMed ID: 9471605
    [No Abstract]   [Full Text] [Related]  

  • 29. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
    Huynh Do P; Joris F
    Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
    Burroni M; Sbano P; Cevenini G; Risulo M; Dell'eva G; Barbini P; Miracco C; Fimiani M; Andreassi L; Rubegni P
    Br J Dermatol; 2005 Apr; 152(4):679-84. PubMed ID: 15840098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The "dysplastic" nevus.
    Friedman RJ; Farber MJ; Warycha MA; Papathasis N; Miller MK; Heilman ER
    Clin Dermatol; 2009; 27(1):103-15. PubMed ID: 19095156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
    Kittler H; Pehamberger H; Wolff K; Binder M
    J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The limited specificity of histological examination in the diagnosis of dysplastic nevi.
    Rabkin MS
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():20-3. PubMed ID: 18976415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new concept of melanocytic neoplasia pathogenesis based on the phenotype of common acquired nevi.
    Batistatou A; Zioga A; Panelos J; Massi D; Agnantis NJ; Charalabopoulos K
    Med Hypotheses; 2007; 69(6):1334-9. PubMed ID: 17459602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulators of malignant melanoma of the skin.
    Cerroni L; Kerl H
    Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
    Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanocytic neoplasms and their etiologic relationship with sunlight.
    Elder DE
    J Invest Dermatol; 1989 May; 92(5 Suppl):297S-303S. PubMed ID: 2654303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.